2030年製藥產業的展望:從進化到革命 | KPMG | TW
close
Share with your friends

2030年製藥產業的展望:從進化到革命

2030年製藥產業的展望:從進化到革命

為了在2030年繼續生存和發展,製藥公司需要進行徹底的改變。

1000

相關內容

隨著醫藥市場日趨著重於醫療效能的可見度,以及從疾病治療到預防醫學的模式改變,將影響當前醫藥市場發展,並為其帶來新的競爭者。

KPMG 全球生命科學團隊(KPMG Global Life Sciences)之最新調查認為願意擁抱改變及轉型之製藥公司,將能借機提升其醫療價值,並於新興的競爭市場中獲得成功。

全球英文版報告下載

中文版報告下載

© 2018 KPMG, the Taiwan member firm of the KPMG network of independent member firms affiliated with KPMG International Cooperative (“KPMG International”), a Swiss entity. All rights reserved.

KPMG International Cooperative (“KPMG International”) is a Swiss entity.  Member firms of the KPMG network of independent firms are affiliated with KPMG International. KPMG International provides no client services. No member firm has any authority to obligate or bind KPMG International or any other member firm vis-à-vis third parties, nor does KPMG International have any such authority to obligate or bind any member firm.

與我們聯繫

 

申請服務建議書

 

填寫申請表單